Pattern of intravesical recurrence after surgical treatment for urothelial cancer of the upper urinary tract

A single institutional retrospective long-term follow-up study

Ei Ichiro Takaoka, Shiro Hinotsu, Akira Joraku, Takehiro Oikawa, Noritoshi Sekido, Naoto Miyanaga, Koji Kawai, Toru Shimazui, Hideyuki Akaza

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Objectives: To estimate the risk of intravesical recurrence in patients with primary urothelial cancer of the upper urinary tract. Methods: Ninety patients who underwent radical nephroureterectomy for clinically localized urothelial cancer of the upper urinary tract were initially considered. Those with a previous and/or concomitant history of bladder cancer, and those who had previously received systemic chemotherapy were excluded. Overall, data from 60 patients with no evidence of bladder cancer and distant or lymph node metastasis were retrospectively reviewed. The clinical course and the risk pattern of intravesical recurrence were estimated by using a smoothing technique on estimated hazard function plots. Multivariate analysis was carried out using a Cox proportional hazards regression model. Results: Mean patient age was 64.7 years. Median follow up was 51.3 months. Thirty patients (50%) had intravesical recurrence during the follow-up period. The peak of intravesical recurrence was detected in the early period (less than 2.5 years) after surgery. The intravesical recurrence hazard became lower afterwards. Nevertheless, it persisted over a long period of time. On univariate and multivariate analyses, none of the clinical or pathological parameters had a statistically significant impact on intravesical recurrence. Conclusions: Even if an intravesical recurrence in patients with upper urinary tract urothelial cancer is more likely in the early period, it persists over a long period of time. This might reflect different mechanisms of recurrence, having a significant impact on the definition of the optimal treatment and follow-up schedules.

Original languageEnglish
Pages (from-to)623-628
Number of pages6
JournalInternational Journal of Urology
Volume17
Issue number7
DOIs
Publication statusPublished - Jul 2010
Externally publishedYes

Fingerprint

Urologic Neoplasms
Recurrence
Therapeutics
Urinary Bladder Neoplasms
Multivariate Analysis
Proportional Hazards Models
Appointments and Schedules
Lymph Nodes
Neoplasm Metastasis
Drug Therapy

Keywords

  • recurrence
  • renal pelvis
  • tumor of bladder
  • ureter
  • urothelial cancer

ASJC Scopus subject areas

  • Urology

Cite this

Pattern of intravesical recurrence after surgical treatment for urothelial cancer of the upper urinary tract : A single institutional retrospective long-term follow-up study. / Takaoka, Ei Ichiro; Hinotsu, Shiro; Joraku, Akira; Oikawa, Takehiro; Sekido, Noritoshi; Miyanaga, Naoto; Kawai, Koji; Shimazui, Toru; Akaza, Hideyuki.

In: International Journal of Urology, Vol. 17, No. 7, 07.2010, p. 623-628.

Research output: Contribution to journalArticle

Takaoka, Ei Ichiro ; Hinotsu, Shiro ; Joraku, Akira ; Oikawa, Takehiro ; Sekido, Noritoshi ; Miyanaga, Naoto ; Kawai, Koji ; Shimazui, Toru ; Akaza, Hideyuki. / Pattern of intravesical recurrence after surgical treatment for urothelial cancer of the upper urinary tract : A single institutional retrospective long-term follow-up study. In: International Journal of Urology. 2010 ; Vol. 17, No. 7. pp. 623-628.
@article{4f8796d8b4a6408b98dcd01928a744c6,
title = "Pattern of intravesical recurrence after surgical treatment for urothelial cancer of the upper urinary tract: A single institutional retrospective long-term follow-up study",
abstract = "Objectives: To estimate the risk of intravesical recurrence in patients with primary urothelial cancer of the upper urinary tract. Methods: Ninety patients who underwent radical nephroureterectomy for clinically localized urothelial cancer of the upper urinary tract were initially considered. Those with a previous and/or concomitant history of bladder cancer, and those who had previously received systemic chemotherapy were excluded. Overall, data from 60 patients with no evidence of bladder cancer and distant or lymph node metastasis were retrospectively reviewed. The clinical course and the risk pattern of intravesical recurrence were estimated by using a smoothing technique on estimated hazard function plots. Multivariate analysis was carried out using a Cox proportional hazards regression model. Results: Mean patient age was 64.7 years. Median follow up was 51.3 months. Thirty patients (50{\%}) had intravesical recurrence during the follow-up period. The peak of intravesical recurrence was detected in the early period (less than 2.5 years) after surgery. The intravesical recurrence hazard became lower afterwards. Nevertheless, it persisted over a long period of time. On univariate and multivariate analyses, none of the clinical or pathological parameters had a statistically significant impact on intravesical recurrence. Conclusions: Even if an intravesical recurrence in patients with upper urinary tract urothelial cancer is more likely in the early period, it persists over a long period of time. This might reflect different mechanisms of recurrence, having a significant impact on the definition of the optimal treatment and follow-up schedules.",
keywords = "recurrence, renal pelvis, tumor of bladder, ureter, urothelial cancer",
author = "Takaoka, {Ei Ichiro} and Shiro Hinotsu and Akira Joraku and Takehiro Oikawa and Noritoshi Sekido and Naoto Miyanaga and Koji Kawai and Toru Shimazui and Hideyuki Akaza",
year = "2010",
month = "7",
doi = "10.1111/j.1442-2042.2010.02539.x",
language = "English",
volume = "17",
pages = "623--628",
journal = "International Journal of Urology",
issn = "0919-8172",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Pattern of intravesical recurrence after surgical treatment for urothelial cancer of the upper urinary tract

T2 - A single institutional retrospective long-term follow-up study

AU - Takaoka, Ei Ichiro

AU - Hinotsu, Shiro

AU - Joraku, Akira

AU - Oikawa, Takehiro

AU - Sekido, Noritoshi

AU - Miyanaga, Naoto

AU - Kawai, Koji

AU - Shimazui, Toru

AU - Akaza, Hideyuki

PY - 2010/7

Y1 - 2010/7

N2 - Objectives: To estimate the risk of intravesical recurrence in patients with primary urothelial cancer of the upper urinary tract. Methods: Ninety patients who underwent radical nephroureterectomy for clinically localized urothelial cancer of the upper urinary tract were initially considered. Those with a previous and/or concomitant history of bladder cancer, and those who had previously received systemic chemotherapy were excluded. Overall, data from 60 patients with no evidence of bladder cancer and distant or lymph node metastasis were retrospectively reviewed. The clinical course and the risk pattern of intravesical recurrence were estimated by using a smoothing technique on estimated hazard function plots. Multivariate analysis was carried out using a Cox proportional hazards regression model. Results: Mean patient age was 64.7 years. Median follow up was 51.3 months. Thirty patients (50%) had intravesical recurrence during the follow-up period. The peak of intravesical recurrence was detected in the early period (less than 2.5 years) after surgery. The intravesical recurrence hazard became lower afterwards. Nevertheless, it persisted over a long period of time. On univariate and multivariate analyses, none of the clinical or pathological parameters had a statistically significant impact on intravesical recurrence. Conclusions: Even if an intravesical recurrence in patients with upper urinary tract urothelial cancer is more likely in the early period, it persists over a long period of time. This might reflect different mechanisms of recurrence, having a significant impact on the definition of the optimal treatment and follow-up schedules.

AB - Objectives: To estimate the risk of intravesical recurrence in patients with primary urothelial cancer of the upper urinary tract. Methods: Ninety patients who underwent radical nephroureterectomy for clinically localized urothelial cancer of the upper urinary tract were initially considered. Those with a previous and/or concomitant history of bladder cancer, and those who had previously received systemic chemotherapy were excluded. Overall, data from 60 patients with no evidence of bladder cancer and distant or lymph node metastasis were retrospectively reviewed. The clinical course and the risk pattern of intravesical recurrence were estimated by using a smoothing technique on estimated hazard function plots. Multivariate analysis was carried out using a Cox proportional hazards regression model. Results: Mean patient age was 64.7 years. Median follow up was 51.3 months. Thirty patients (50%) had intravesical recurrence during the follow-up period. The peak of intravesical recurrence was detected in the early period (less than 2.5 years) after surgery. The intravesical recurrence hazard became lower afterwards. Nevertheless, it persisted over a long period of time. On univariate and multivariate analyses, none of the clinical or pathological parameters had a statistically significant impact on intravesical recurrence. Conclusions: Even if an intravesical recurrence in patients with upper urinary tract urothelial cancer is more likely in the early period, it persists over a long period of time. This might reflect different mechanisms of recurrence, having a significant impact on the definition of the optimal treatment and follow-up schedules.

KW - recurrence

KW - renal pelvis

KW - tumor of bladder

KW - ureter

KW - urothelial cancer

UR - http://www.scopus.com/inward/record.url?scp=77953837454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953837454&partnerID=8YFLogxK

U2 - 10.1111/j.1442-2042.2010.02539.x

DO - 10.1111/j.1442-2042.2010.02539.x

M3 - Article

VL - 17

SP - 623

EP - 628

JO - International Journal of Urology

JF - International Journal of Urology

SN - 0919-8172

IS - 7

ER -